GO:0035162 embryonic hemopoiesis: Developmental Hematopoiesis, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0035162 embryonic hemopoiesis describes the stages of blood cell formation that occur within the embryo [2, 5].
• Embryonic hemopoiesis proceeds through primitive and definitive waves, with the yolk sac, aorta-gonad-mesonephros (AGM) region, and fetal liver as key anatomical sites [2, 5, 6, 8].
• Primitive macrophages produced during embryonic hemopoiesis give rise to adult microglia and other tissue-resident macrophage populations [1, 4].
• The AGM region is the principal source of definitive hematopoietic stem cells (HSCs) that seed the fetal liver and later the bone marrow [6, 7, 8].
• Embryonic macrophages actively regulate the niche that supports HSC emergence, linking innate immune cells to stem cell pool establishment.
• CRISPR-based knockout, knock-in, and overexpression models in mice and human pluripotent stem cells are essential for dissecting embryonic hemopoiesis gene function [5, 6, 8].
Description
Embryonic hemopoiesis (GO:0035162) is the biological process encompassing all stages of blood cell formation that take place within the embryo [2, 5]. Unlike adult hematopoiesis, which occurs primarily in the bone marrow, embryonic hemopoiesis is a spatially and temporally dynamic process that begins in the yolk sac and sequentially involves the aorta-gonad-mesonephros (AGM) region, the placenta, and the fetal liver [2, 5, 6, 8]. This process is essential for oxygen transport, immune surveillance, and the establishment of the definitive hematopoietic stem cell (HSC) pool that sustains blood production throughout life [6, 7, 8]. Researchers study embryonic hemopoiesis to understand the developmental origins of the blood system, the specification of tissue-resident macrophages, and the molecular cues that instruct HSC emergence [1, 4, 7]. Because defects in embryonic hemopoiesis can lead to severe congenital blood disorders, immune deficiencies, and leukemia predisposition, this GO term is a focal point for developmental biology, immunology, and regenerative medicine [2, 5, 8]. This article provides a research-grade overview of GO:0035162, integrating the QuickGO definition with verified findings from PubMed literature. It covers the anatomical sites, cellular stages, key genes, regulatory mechanisms, disease associations, and CRISPR-based experimental models used to investigate embryonic hemopoiesis.
embryonic hemopoiesis At A Glance
| GO ID | GO:0035162 |
|---|---|
| GO term | embryonic hemopoiesis |
| Ontology | biological_process |
| Synonym | embryonic haematopoiesis, embryonic haemopoiesis, embryonic hematopoiesis |
| Definition | The stages of blood cell formation that take place within the embryo. |
| Major function | Production of blood cells during embryonic development, including primitive and definitive waves. |
| Key anatomical sites | Yolk sac, AGM region, placenta, fetal liver |
| Key cell types | Primitive erythrocytes, embryonic macrophages, definitive HSCs, megakaryocytes |
| Related processes | HSC emergence, macrophage specification, erythropoiesis, myelopoiesis |
What Is GO:0035162?
Embryonic hemopoiesis (GO:0035162) is defined as the stages of blood cell formation that take place within the embryo [2, 5]. It encompasses the generation of primitive erythrocytes, macrophages, and megakaryocytes in the yolk sac, as well as the emergence of definitive hematopoietic stem cells in the AGM region and their subsequent expansion and differentiation in the fetal liver [2, 5, 6, 8]. This process is distinct from adult hematopoiesis in its anatomical sites, lineage output, and regulatory signals [2, 5].
Why Is embryonic hemopoiesis Important in Cell Biology?
Embryonic hemopoiesis is critically important because it establishes the first blood cells that support embryonic survival and lays the foundation for the lifelong hematopoietic system [2, 5, 6]. Defects in this process cause embryonic lethality, congenital anemias, and immune deficiencies, while dysregulation of embryonic hematopoietic programs can contribute to pediatric leukemias [2, 5, 8]. Understanding GO:0035162 also informs regenerative medicine efforts to generate HSCs and immune cells from pluripotent stem cells [5, 8].
• Provides the first oxygen-carrying erythrocytes required for embryonic growth.
• Generates primitive macrophages that seed adult microglia and tissue-resident macrophages [1, 4].
• Establishes the definitive HSC pool that maintains adult hematopoiesis [6, 7, 8].
• Defects cause embryonic lethality and congenital blood disorders [2, 5].
• Dysregulation is linked to infant leukemias and bone marrow failure syndromes [5, 8].
• Serves as a paradigm for understanding stem cell emergence and niche interactions.
• Informs in vitro differentiation protocols for HSCs from iPSCs [5, 8].
• Reveals evolutionary conservation of blood development across vertebrates.
• Provides targets for gene therapy of hemoglobinopathies [2, 8].
• Links developmental immunology with stem cell biology [4, 7].
What Happens During embryonic hemopoiesis?
Primitive wave in the yolk sac
In simple terms: The first blood cells are made in the yolk sac to quickly supply oxygen and immune cells to the growing embryo.
The primitive wave of embryonic hemopoiesis begins in the yolk sac blood islands, where mesodermal progenitors differentiate into primitive erythrocytes, macrophages, and megakaryocytes [2, 5]. These primitive erythrocytes are large, nucleated, and express embryonic globins to facilitate oxygen transport in the low-oxygen embryonic environment. Primitive macrophages produced at this stage migrate to the embryo proper and later give rise to adult microglia and other tissue-resident macrophages [1, 4].
Definitive HSC emergence in the AGM region
In simple terms: A second wave produces true blood stem cells in a region called the AGM, which will supply all blood cells for life.
The definitive wave of embryonic hemopoiesis is marked by the emergence of hematopoietic stem cells (HSCs) from the ventral wall of the dorsal aorta in the aorta-gonad-mesonephros (AGM) region [6, 8]. These HSCs arise from hemogenic endothelium through an endothelial-to-hematopoietic transition and are characterized by expression of markers such as CD34, c-Kit, and Runx1 [6, 8]. The AGM region is considered the primary source of definitive HSCs in the embryo [6, 8].
Fetal liver colonization and expansion
In simple terms: The new blood stem cells move to the fetal liver, where they multiply and start making all types of blood cells.
After emerging in the AGM, definitive HSCs colonize the fetal liver, which becomes the major site of hematopoiesis during mid-to-late gestation [2, 3, 8]. In the fetal liver, HSCs undergo extensive expansion and differentiation into erythroid, myeloid, and lymphoid progenitors [3, 8]. The fetal liver microenvironment provides essential niche factors, including cytokines and extracellular matrix components, that support HSC self-renewal and lineage commitment [3, 8].
Macrophage-mediated niche regulation
In simple terms: Special immune cells called macrophages help create a supportive environment for blood stem cells to grow.
Embryonic macrophages play a critical role in orchestrating the niche for HSC emergence and expansion. These macrophages interact with niche cells to maintain homeostasis and promote the establishment of the definitive HSC pool. Depletion of embryonic macrophages impairs HSC emergence, highlighting their non-cell-autonomous function in embryonic hemopoiesis.
Transition to bone marrow hematopoiesis
In simple terms: Before birth, blood production shifts from the fetal liver to the bone marrow, where it continues after birth.
As development progresses, hematopoietic activity gradually transitions from the fetal liver to the bone marrow, which becomes the primary site of hematopoiesis after birth [2, 5]. This transition involves the migration of HSCs to the bone marrow cavity and the establishment of the adult hematopoietic niche [2, 5]. The molecular signals controlling this switch include chemokines, adhesion molecules, and developmental cues [2, 5].
Key Genes Involved in GO:0035162 embryonic hemopoiesis
The following genes are central to embryonic hemopoiesis, based on published functional studies in mouse and human models.
| Gene | Major Role | Research Relevance |
|---|---|---|
| RUNX1 | Essential for HSC emergence from hemogenic endothelium | Knockout causes embryonic lethality and absence of definitive HSCs [6, 8] |
| SCL/TAL1 | Master regulator of hematopoietic specification | Required for primitive and definitive hematopoiesis [5, 6] |
| LMO2 | Transcription factor in hematopoietic development | Knockout leads to severe anemia and embryonic death [5, 6] |
| GATA2 | Regulates HSC generation and maintenance | Haploinsufficiency causes immunodeficiency and lymphedema [5, 8] |
| KIT | Receptor tyrosine kinase for HSC survival and proliferation | Mutations affect HSC emergence and migration [6, 8] |
| CD34 | Marker of hematopoietic progenitors | Used to identify and isolate HSCs [6, 8] |
| PTPRC (CD45) | Pan-leukocyte marker | Distinguishes hematopoietic cells from endothelium |
| CXCR4 | Chemokine receptor for HSC migration | Knockout impairs fetal liver colonization [6, 8] |
| GATA1 | Erythroid and megakaryocytic differentiation | Mutations cause anemia and thrombocytopenia [2, 5] |
| KLF1 | Erythroid maturation and globin switching | Defects lead to congenital dyserythropoietic anemia |
| MYB | Required for definitive hematopoiesis | Knockout causes embryonic lethality due to anemia |
| NOTCH1 | Regulates HSC emergence and arterial identity | Inhibition blocks hemogenic endothelium formation [6, 8] |
| SOX17 | Specifies hemogenic endothelium | Knockdown reduces HSC emergence |
| HOXB4 | Promotes HSC self-renewal | Overexpression expands HSCs in vivo |
| MEIS1 | Regulates HSC proliferation and leukemogenesis | Knockout reduces HSC repopulation |
| FLT3 | Cytokine receptor for lymphoid and myeloid progenitors | Mutations associated with leukemia |
| CSF1R | Macrophage differentiation and survival | Essential for primitive macrophage development [1, 4] |
How Is embryonic hemopoiesis Regulated?
Embryonic hemopoiesis is regulated by a complex interplay of transcription factors, signaling pathways, and niche-derived cues [5, 6, 8]. Key transcriptional regulators include RUNX1, SCL/TAL1, GATA2, and LMO2, which form a core heptad complex that drives hematopoietic specification [5, 6]. Signaling pathways such as Notch, Wnt, and BMP are critical for HSC emergence in the AGM region [6, 8]. Inflammatory signaling, including interferon and Toll-like receptor pathways, has also been implicated in HSC emergence. Additionally, embryonic macrophages provide essential niche signals that maintain the microenvironment for HSC development. The transition from primitive to definitive hematopoiesis is further controlled by oxygen-sensing pathways and metabolic cues [2, 5].
embryonic hemopoiesis and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| RUNX1 | Familial platelet disorder with predisposition to AML | Knockout and point-mutation mice; human iPSC-derived HSCs [5, 8] |
| GATA2 | GATA2 deficiency with immunodeficiency and lymphedema | Conditional knockout mice; patient-derived iPSCs [5, 8] |
| CSF1R | Hereditary diffuse leukoencephalopathy with spheroids | Knock-in mice with CSF1R mutations; microglial differentiation from iPSCs [1, 4] |
| KLF1 | Congenital dyserythropoietic anemia type IV | Knockout and knock-in mice; erythroid differentiation assays |
| HOXB4 | Leukemia predisposition | Overexpression and knockout mice; HSC expansion assays |
Congenital blood disorders
Mutations in genes essential for embryonic hemopoiesis cause severe congenital disorders. For example, RUNX1 mutations are associated with familial platelet disorder with predisposition to acute myeloid leukemia, while GATA2 haploinsufficiency leads to immunodeficiency and bone marrow failure [5, 8]. Defects in globin gene regulation during primitive erythropoiesis can result in hemoglobinopathies such as beta-thalassemia.
Pediatric leukemias
Dysregulation of embryonic hematopoietic programs can contribute to pediatric leukemias. Aberrant expression of HOXB4, MEIS1, or FLT3 during fetal hematopoiesis is linked to acute lymphoblastic and myeloid leukemias [5, 6]. The fetal liver niche may provide a permissive environment for leukemic transformation.
Immune deficiencies and macrophage disorders
Embryonic macrophages are the precursors of tissue-resident macrophages, including microglia [1, 4]. Defects in CSF1R signaling cause hereditary diffuse leukoencephalopathy with spheroids, a microglial disorder [1, 4]. Impaired macrophage development during embryogenesis can lead to increased susceptibility to infections and inflammatory diseases [4, 7].
From embryonic hemopoiesis-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does gene X regulate HSC emergence? | Knockout mouse (constitutive or conditional) [6, 8] |
| Does a point mutation in gene Y cause congenital anemia? | Point-mutation knock-in mouse [2, 5] |
| Can gene Z rescue HSC defects? | Knock-in of wild-type or mutant cDNA [6, 8] |
| Where is protein X expressed during embryonic hemopoiesis? | Tagged knock-in (e.g., GFP, HA) [6, 8] |
| Does overexpression of gene A expand HSCs? | Transgenic overexpression or lentiviral transduction |
| What is the role of macrophage-derived factor B? | Conditional knockout in macrophages |
How to Study the embryonic hemopoiesis Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Lineage tracing | Fate of progenitor cells | Tracking macrophage and HSC origins [1, 4] |
| scRNA-seq | Transcriptional heterogeneity | Identifying novel progenitors in AGM and fetal liver [5, 8] |
| In vitro differentiation | Hematopoietic potential of stem cells | Modeling human blood development [5, 8] |
| Imaging | Spatial and temporal dynamics | Visualizing HSC emergence [6, 7] |
| Spatial transcriptomics | Gene expression in tissue context | Mapping niche signals [6, 7] |
| Flow cytometry | Cell surface marker expression | Isolating HSC and progenitor populations [6, 8] |
| Colony-forming assays | Clonogenic potential | Assessing differentiation capacity [2, 5] |
| Transplantation assays | HSC repopulation ability | Testing definitive HSC function [6, 8] |
Lineage tracing and fate mapping
Lineage tracing using Cre-loxP or inducible systems allows researchers to track the fate of embryonic hematopoietic progenitors [1, 4]. For example, fate mapping has shown that primitive macrophages give rise to adult microglia. This method is essential for understanding the developmental origins of blood lineages [1, 4].
Single-cell RNA sequencing
Single-cell RNA sequencing (scRNA-seq) enables the dissection of cellular heterogeneity during embryonic hemopoiesis [5, 8]. It has been used to identify novel progenitor populations and to reconstruct differentiation trajectories in the AGM and fetal liver [5, 8]. This technique is powerful for discovering new markers and regulatory networks [5, 8].
In vitro differentiation of pluripotent stem cells
Human and mouse pluripotent stem cells can be differentiated into hematopoietic cells in vitro, recapitulating key aspects of embryonic hemopoiesis [5, 8]. This system allows functional testing of gene mutations and potential therapeutics [5, 8]. It is particularly useful for studying human-specific aspects of blood development [5, 8].
Imaging and spatial transcriptomics
Live imaging and spatial transcriptomics provide spatial and temporal resolution of hematopoietic emergence in the embryo [6, 7]. These methods have revealed dynamic interactions between hemogenic endothelium and surrounding niche cells [6, 7]. They are critical for understanding the microenvironmental regulation of HSC emergence [6, 7].
How CRISPR Can Be Used to Study GO:0035162 embryonic hemopoiesis
Knockout
CRISPR-Cas9 knockout is widely used to study gene function in embryonic hemopoiesis. For example, knockout of RUNX1 in mouse embryos abolishes HSC emergence, demonstrating its essential role [6, 8]. Knockout models can be generated in mice, zebrafish, or human iPSCs to assess loss-of-function phenotypes [5, 6, 8].
Point Mutation
CRISPR-mediated point mutations allow precise modeling of disease-associated variants. For instance, introducing a point mutation in GATA2 can recapitulate immunodeficiency phenotypes in iPSC-derived hematopoietic cells [5, 8]. This approach is valuable for understanding how specific amino acid changes affect protein function during development [5, 8].
Knock-in
Knock-in of reporter genes (e.g., GFP) or epitope tags enables visualization and tracking of specific cell populations during embryonic hemopoiesis [6, 8]. Knock-in of human disease alleles into mouse models provides a platform for testing therapeutics [5, 8]. This technique is also used to create conditional alleles for spatial and temporal control.
Overexpression
CRISPR activation (CRISPRa) or transgenic overexpression can be used to study gain-of-function effects. Overexpression of HOXB4 expands HSCs in vivo, highlighting its potential for regenerative medicine. Overexpression models help identify sufficiency of a gene in driving hematopoietic programs [5, 6].
How EDITGENE Supports embryonic hemopoiesis Research
Researchers studying embryonic hemopoiesis-related genes often need to determine whether a candidate gene is causally involved in HSC emergence, macrophage specification, or erythroid differentiation. EDITGENE provides a comprehensive suite of CRISPR-based services to accelerate this discovery process, from knockout to knock-in and library screening.
Contact EDITGENE today to design your custom CRISPR model for embryonic hemopoiesis research.
Related Products
| Product name | Cat.No. | Species | Gene ID | |
|---|---|---|---|---|
| ATF4 Knockout HEK293 Cell Line | EDJ-KQ611 | Human | 468 | Details Get a Quote |
| KITLG Knockout HEK293 Cell Line | EDJ-KQ680 | Human | 4254 | Details Get a Quote |
| FLT3LG Knockout HEK293 Cell Line | EDJ-KQ1200 | Human | 2323 | Details Get a Quote |
| TAL1 Knockout HEK293 Cell Line | EDJ-KQ1647 | Human | 6886 | Details Get a Quote |
| TPO Knockout HEK293 Cell Line | EDJ-KQ2905 | Human | 7173 | Details Get a Quote |
| LMO2 Knockout HEK293 Cell Line | EDJ-KQ5130 | Human | 4005 | Details Get a Quote |
| SH2B3 Knockout HEK293 Cell Line | EDJ-KQ6867 | Human | 10019 | Details Get a Quote |
| BLOC1S2 Knockout HEK293 Cell Line | EDJ-KQ12538 | Human | 282991 | Details Get a Quote |
| ZFPM1 Knockout HEK293 Cell Line | EDJ-KQ16221 | Human | 161882 | Details Get a Quote |
| KDR Knockout HEK293 Cell Line | EDJ-KQ17675 | Human | 3791 | Details Get a Quote |
| IL3 Knockout HEK293 Cell Line | EDJ-KQ17694 | Human | 3562 | Details Get a Quote |
| TGFBR2 Knockout HEK293 Cell Line | EDC07591 | Human | 7048 | Details Get a Quote |
| KIT Knockout HEK293 Cell Line | EDJ-KQ17830 | Human | 3815 | Details Get a Quote |
| ATF4 Knockout A-549 Cell Line | EDJ-KQ18171 | Human | 468 | Details Get a Quote |
| ATF4 Knockout HCT 116 Cell Line | EDJ-KQ19071 | Human | 468 | Details Get a Quote |
Displaying Records 1 To 15 Of 66 Records
- 1
- 2
- Next Page »
Frequently Asked Questions About embryonic hemopoiesis
What is embryonic hemopoiesis?
Embryonic hemopoiesis (GO:0035162) is the process of blood cell formation that occurs within the embryo, including primitive and definitive waves [2, 5].
What genes are involved in embryonic hemopoiesis?
Key genes include RUNX1, SCL/TAL1, GATA2, LMO2, KIT, and CSF1R, among others [5, 6, 8].
Where does embryonic hemopoiesis occur?
It occurs sequentially in the yolk sac, AGM region, placenta, and fetal liver [2, 5, 6, 8].
What is the difference between primitive and definitive hematopoiesis?
Primitive hematopoiesis produces mainly erythrocytes and macrophages in the yolk sac, while definitive hematopoiesis generates HSCs that sustain lifelong blood production [2, 5].
How is embryonic hemopoiesis studied?
It is studied using mouse genetics, lineage tracing, scRNA-seq, in vitro differentiation of pluripotent stem cells, and imaging [1, 4, 5, 6, 8].
What diseases are linked to defects in embryonic hemopoiesis?
Defects can cause congenital anemias, immune deficiencies, and pediatric leukemias [2, 5, 8].
What is the role of macrophages in embryonic hemopoiesis?
Embryonic macrophages regulate the niche for HSC emergence and give rise to tissue-resident macrophages including microglia [1, 4, 7].
Can CRISPR be used to study embryonic hemopoiesis?
Yes, CRISPR knockout, knock-in, point mutation, and overexpression models are widely used to dissect gene function in this process [5, 6, 8].
What is the AGM region?
The aorta-gonad-mesonephros (AGM) region is the primary site of definitive HSC emergence during embryonic development [6, 8].
Why is embryonic hemopoiesis important for regenerative medicine?
Understanding it informs efforts to generate HSCs and immune cells from pluripotent stem cells for therapy [5, 8].
Conclusion
Embryonic hemopoiesis (GO:0035162) is a fundamental developmental process that establishes the blood system and immune cell repertoire. Research over the past decades has elucidated the anatomical sites, cellular stages, and molecular regulators of this process, revealing its critical roles in health and disease [2, 5, 6, 8]. Continued investigation using advanced CRISPR models and single-cell technologies will further unravel the complexities of embryonic blood development and translate these insights into regenerative therapies [5, 7, 8].
References
- 1. Ginhoux F et al.. 2010. Fate mapping analysis reveals that adult microglia derive from primitive macrophages.. Science 330(6005):841-5 PMID: 20966214
- 2. Tavassoli M. 1991. Embryonic and fetal hemopoiesis: an overview.. Blood Cells 17(2):269-81; discussion 282-6 PMID: 1912596
- 3. Timens W et al.. 1997. Hemopoiesis in human fetal and embryonic liver.. Microsc Res Tech 39(5):387-97 PMID: 9408905
- 4. Mass E et al.. 2016. Specification of tissue-resident macrophages during organogenesis.. Science 353(6304) PMID: 27492475
- 5. Golub R et al.. 2013. Embryonic hematopoiesis.. Blood Cells Mol Dis 51(4):226-31 PMID: 24041595
- 6. Dzierzak E et al.. 1995. Mouse embryonic hematopoiesis.. Trends Genet 11(9):359-66 PMID: 7482788
- 7. Perçin G et al.. 2025. Embryonic macrophages orchestrate niche cell homeostasis for the establishment of the definitive hematopoietic stem cell pool.. Nat Commun 16(1):4428 PMID: 40368907
- 8. Tavian M et al.. 2010. Embryonic origin of human hematopoiesis.. Int J Dev Biol 54(6-7):1061-5 PMID: 20711983
